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Abstract
Mapping energy landscapes has proved to be a powerful tool for studying reaction mechanisms. 
Many complex biomolecular assembly processes, however, have remained challenging to access 
using this approach, including the aggregation of peptides and proteins into amyloid fibrils 
implicated in various disorders. Here we generalize the strategy used to probe energy landscapes 
in protein folding to determine the activation energies and entropies that characterise each of the 
molecular steps in the aggregation of the amyloid-β peptide (Aβ42), which is associated with 
Alzheimer’s disease. Our results reveal that interactions between monomeric Aβ and amyloid 
fibrils during fibril-dependent nucleation fundamentally reverse the thermodynamic signature of 
this process relative to primary nucleation, even though both processes generate aggregates from 
soluble peptides. By mapping the energetic and entropic contributions along the reactive 
trajectories, we show that the catalytic efficiency of Aβ42 fibril surfaces results from the enthalpic 
stabilisation of adsorbing peptides in conformations amenable to nucleation, driving a dramatic 
lowering of the activation energy barrier for nucleation.
The aberrant self-assembly of proteins and peptides into amyloid fibrils is implicated in the 
pathology of over 30 clinical disorders, including Alzheimer’s and Parkinson’s diseases1–3. 
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Although it is a priority of both fundamental and translational research to characterise the 
molecular-level processes involved in amyloid formation4–7, this has proved challenging to 
achieve in practice7–9. Recently, however, advances in both experimental7, 10 and 
theoretical7, 11 methods have made it possible to acquire highly reproducible kinetic data in 
solution7, 10 under a wide range of experimental conditions, and to connect these 
measurements with the underlying microscopic processes through chemical kinetic rate 
laws5, 11. In the case of the 42-residue amyloid-β peptide (Aβ42), the aggregation of which 
is associated with Alzheimer’s disease, the key molecular steps in amyloid formation have 
been identified7 as the primary nucleation of new aggregates from monomers4, 6, 12, the 
addition of monomers to fibril ends resulting in their elongation13–15, and secondary 
nucleation of monomers involving the fibril surface7, 16.
This latter secondary nucleation process is a defining feature of Aβ42 aggregation7, 16, and 
several other amyloid systems8, 17, 18, and plays a key role in generating the high levels of 
toxicity associated with this peptide19–22, as well as potentially playing an important role in 
the spreading of the pathology in the brain23–25. The secondary nucleation process involves 
the surfaces of existing amyloid fibrils catalysing the formation of new pre-fibrillar 
aggregates from the soluble peptide26. Since the aggregates generated in this manner can 
grow into fibrils and subsequently catalyse additional nucleation events, the secondary 
nucleation step results in positive feedback and a chain reaction which underlies the 
autocatalytic nature of amyloid formation7, 9, 16. Furthermore, although the pre-fibrillar 
aggregates, also called oligomers, which are generated by both the primary and secondary 
nucleation processes are likely to be toxic to cells7, 19–22, once a small but critical 
concentration of Aβ42 fibrils is present, the concentration of toxic oligomers generated 
through the secondary nucleation process rapidly exceeds that generated by primary 
nucleation7.
Although the fundamental steps involved in Aβ amyloid formation have been identified, the 
molecular mechanisms underlying these nucleation and growth processes remain poorly 
understood. In the study of protein folding dynamics, the key to overcoming this same 
challenge has been to probe the energy landscape associated with the folding process, in 
practice by establishing the activation free energy, and the component enthalpic and entropic 
contributions from thermodynamic analysis of experimental data acquired across a range of 
temperatures. Here, we generalize this approach to describe complex protein self-assembly 
processes that involve multiple molecular events occurring simultaneously across 
heterogeneous size distributions of aggregates. We achieve this goal through advances in 
experimental and theoretical chemical kinetics that make it possible to decouple from 
measurements of the overall aggregation reaction the characteristic signatures of the 
individual steps in amyloid formation, each of which can then be analysed using the same 
approach used in protein folding dynamics.
Using this strategy, we determine the activation free energies of fibril elongation, primary 
nucleation and secondary nucleation in Aβ42 amyloid formation, and the enthalpic and 
entropic contributions to these barriers. The results uncover striking similarities between the 
interactions driving the elongation of fibrils and primary nucleation, but expose the 
secondary nucleation process as having an entirely different thermodyamic character from 
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primary nucleation. This contrast in the thermodynamic signatures of the two nucleation 
processes occurs despite the fact that both processes generate new aggregates from 
monomers, indicating that the molecular nature of the fibril surface and its interactions with 
monomers plays a critical role in secondary nucleation. By probing directly the interactions 
between monomeric peptides and fibrils, we map the energy landscape that characterises 
secondary nucleation, revealing how the interactions between monomers and the surfaces of 
amyloid fibrils drive a dramatic reduction in the activation energy for nucleation.
Results
Global analysis of Aβ42 aggregation at different temperatures
We explored the kinetics of aggregation of the amyloid-β (M1–42) peptide, referred to here 
as Aβ42, across a range of concentrations and temperatures. In order to establish well-
defined initial conditions for the kinetic experiments, and hence to obtain reproducible data, 
it is crucial to use highly purified sequence homogeneous recombinant Aβ42 together with 
repeated isolation of monomers through size-exclusion chromatography, and to control 
carefully the inertness of surfaces with which the peptide makes contact7, 10. Furthermore, 
to accurately decouple the temperature and concentration dependence of the individual 
reaction rates, the relative initial concentrations of monomeric peptide used at each 
temperature must be known to a very high degree of accuracy, since the reaction rates for 
this peptide are highly sensitive to the concentration of monomers in addition to the 
temperature7. To address this challenge, we arranged to carry out our experiments in 
parallel, using monomer solutions prepared simultaneously by dilution from a single master 
stock of Aβ42 and loaded in parallel into an array of fluorescence plate readers with the 
temperature of each device held constant at a different temperature.
We first monitored the concentration-dependent kinetics of the aggregation of Aβ42 under 
quiescent condition for reactions beginning from purely monomeric peptide at seven 
different temperatures (Fig. 1). We carried out two sets of experiments, each involving four 
different temperatures, and included measurements at 36°C in both data sets to verify the 
high level of reproducibility across the two sets of data. At higher reaction temperatures, we 
observed an increase in the overall rate of formation of fibrils and characteristic changes in 
the time course of the reaction. At all temperatures and monomer concentrations we observe 
sigmoidal-like kinetic traces with a noticeable decrease in the sharpness of the transition as 
the temperature increases (Supplementary Fig. 2). To connect these macroscopic 
observations with the underlying microscopic processes, we applied an analytical approach, 
based on the integrated rate law that describes the aggregation of Aβ42, to determine the 
values of the rate constants controlling the reaction at each temperature5, 7, 27. Specifically, 
although there are distinct microscopic rate constants for fibril elongation (k+), primary 
nucleation (kn) and secondary nucleation (k2), the integrated rate law for Aβ aggregation7, 
27 shows that the macroscopic reaction profiles, for reactions beginning from purely 
monomeric peptide, are controlled by just two combinations of these rate constants, k+kn 
and k+k2. Remarkably, at each temperature, we are able to fit essentially perfectly all of the 
data across multiple concentrations (Fig. 1a–g) using just these two kinetic parameters fixed 
Cohen et al. Page 3
Nat Chem. Author manuscript; available in PMC 2018 September 26.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
globally across the entire data set, providing values for these combined rate parameters at 
each temperature (Fig. 3b,c).
In order to decouple the values of the individual rate constants from the combined 
parameters k+kn and k+k2, it is necessary to determine one of the rate constants in isolation. 
To achieve this goal we measured reaction profiles from solutions containing not only 
monomeric peptide but also pre-formed fibrils (Fig. 2). At sufficiently high concentrations of 
pre-formed fibrils11 (here ca. 40% or greater of the total peptide concentration), the rate 
equations indicate that the elongation of fibrils is the dominant process and that the 
nucleation processes can be neglected, allowing determination of the elongation rate 
constant in isolation11. More precisely, the reaction profiles under these conditions depend 
primarily on the value k+/L(0)11, where L(0) is the mean length of the pre-formed fibrils 
present at the start of the reaction, which can be estimated independently using cryogenic 
transmission electron microscopy (Supplementary Fig. 3). In order to ensure that L(0) was 
consistent across all of our experiments, we used pre-formed fibrils generated at a single 
temperature (36°C). We also observed that the temperature at which pre-formed fibrils were 
generated did not significantly impact their ability to act as reactive fibril ends 
(Supplementary Fig. 3), and analyses by TEM and differential centrifugal sedimentation 
(Supplementary Fig. 4) were consistent with the prediction from the kinetic analysis7 that 
the mean length of fibrils, μ, generated in the aggregation reaction increases at higher 
temperatues, since μ ∼ k+/k2 . Interestingly, by contrast to aggregation from purely 
monomeric peptide, the integrated rate law in the case of heavily pre-seeded reactions 
indicates that the normalized reaction profiles will be only weakly sensitive to the initial 
concentration of peptides11. The global fits to the data (Fig. 2a–d) in this case provide a 
direct estimate of the elongation rate constant k+ at each temperature. We find that k+ 
increases with temperature, which is reflected in our measurements (Fig. 2) by a steeper 
initial slope at higher temperatures.
Arrhenius behaviour for combined rate constants
The global analyses in Figs. 1 and 2 provide values for the combined rate parameters k+kn 
and k+k2, and the elongation rate constant k+ at a variety of temperatures. These 
measurements together make it possible to decouple the values and temperature 
dependences of the individual rate constants k+, kn and k2, which describe transitions from 
well-defined initial to final states7, 11 on a free energy landscape. By analogy with protein 
folding28, 29, we extract the essential features of the free energy landscapes that are 
associated with the elongation of fibrils and the nucleation events by describing each of 
these processes as diffusive motions along one-dimensional free energy surfaces. Kramers 
theory28–31 provides the temperature dependence of the rate constants (k+, kn and k2) in the 
form of an Arrhenius equation which directly links a kinetic rate constant to the 
corresponding highest energy barrier along the potential landscape measured relative to the 
starting point: k = A exp(−Δ G
‡ϴ
RT ) for a rate constant k, highest free energy barrier ΔG
‡ϴ
, and 
temperature T. It is important to note that, although the energy landscape may include 
multiple intermediate barriers, only the highest free energy barrier measured relative to the 
starting point enters the various rate constants and hence is directly probed by these 
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experiments (see the Supplementary Note for a detailed discussion of the application of 
Kramers theory to biomolecular reactions). Where the rate laws contain products of the 
individual rate constants (i.e. k+kn or k+k2), the same temperature dependence is maintained 
with the component activation energies appearing summed in the exponent: 
k1k2 = A1A2 exp( −
Δ G1
‡ϴ + Δ G2
‡ϴ
RT ) .
We first checked whether or not plots of the logarithms of the reaction rates against the 
inverse absolute temperatures were linear over the temperature range used (Fig. 3). 
Interestingly, we observed linearity of the Arrhenius plots in all three cases, indicating that 
well-defined activation energies characterize the distinct microscopic processes of fibril 
elongation, primary nucleation and secondary nucleation, and that any changes in heat 
capacity, ΔCp = ∂ΔH‡ϴ/∂T, between the starting states and transition states of the three 
processes were small over the temperature range studied. Since the free energy barrier ΔG‡ϴ 
associated with each process is related to the enthalpy ΔH‡ϴ and entropy ΔS‡ϴ of activation 
through the relationship ΔG‡ϴ = ΔH‡ϴ−TΔS‡ϴ, the enthalpies of the microscopic processes 
can be directly determined from the gradient of each plot according to ∂(log k)/∂(1/T) = 
−ΔH‡ϴ/R (Fig. 3a) or ∂(log k1k2)/ ∂(1/T) = − ( Δ H1‡ϴ + Δ H2‡ϴ)/R (Fig. 3b–c).
As a means to determine the free energy barrier ΔG‡ϴ, and hence also the entropy of 
activation using −TΔS‡ϴ = ΔG‡ϴ−ΔH‡ϴ, an independent estimate of the prefactor A is 
needed, although ΔG‡ϴ has only a logarithmic dependence on this value. The prefactor A 
can be thought of as the frequency of attempts at a given reaction, which is multiplied by 
exp(−Δ G
‡ϴ
RT ) to obtain the rate of successful (i.e. barrier-crossing) attempts at the reaction. 
We have in the past reported an estimate of the prefactor for amyloid fibril elongation, based 
on modeling the elongating monomer as a Gaussian chain that diffusively crosses the energy 
barrier and escapes from the metastable soluble state32. Given the fundamentally limited 
information about diffusion along the reaction coordinates for the nucleation processes, we 
partition all of the missing information into the free energy barrier in the rate equation. Other 
choices for the pre-factors are possible (for example, incorporating the process of monomer 
adsorption), and as such the free energy barrier is only meaningful if stated together with the 
corresponding pre-factor. The prefactor can be expressed as A ~ Dreff with a characteristic 
diffusion constant D ~ 10−9m2s−1 and the radius of the effective reaction volume reff ~ 
3·10−11m in the case of the Aβ peptide32, 33. An analogous approach can be applied for the 
nucleation processes (see the Supplementary Note for the derivation), accounting for the 
different species involved in each process. Overall, the pre-factors for the nucleation 
processes are likely to involve characteric diffusion constants and effective length scales of 
the same order of magnitude as fibril elongation32, although the concentration dependence 
of the pre-factor must be scaled to account for the reaction order of each process.
Hence, the measurements of the molecular rate constants together with the Arrhenius plots 
provide values for the free energy, enthalpy and entropy of activation for fibril elongation 
(Fig. 3a), and the sums of these barriers for elongation and primary nucleation (Fig. 3b), and 
elongation and secondary nucleation (Fig. 3c). Moreover, using the temperature dependence 
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of the elongation rate constant k+, we are able to resolve the temperature dependence of the 
nucleation rate constants kn and k2 from the combined rate parameters k+kn and k+k2 (Fig. 
3d). We note that while the rates of both fibril elongation and primary nucleation increase 
strongly as temperature rises, the secondary nucleation rate is observed to have a much 
weaker dependence on temperature. These data explain the observed increase in the 
sharpness of the transition of the reaction profiles at lower temperatures (Supplementary Fig. 
2), since the ratio of the rates of secondary to primary pathways increases7 at lower 
temperatures. We verified the continuation of this trend by monitoring aggregation reactions 
at temperatures as low as 10°C (Supplementary Fig. 2).
Activation energies of distinct molecular steps
The values determined from Fig. 3 for the barriers in free energy, and the enthalpic and 
entropic contributions, reveal the individual energy barriers associated with the three key 
molecular steps in the aggregation of Aβ42 to form amyloid fibrils (Fig. 4). The results for 
elongation reveal a small free energy barrier Δ G+
‡ϴ = 5 ± 1 kJ mol−1, with an enthalpic 
barrier ( Δ H+
‡ϴ > 0) and a favourable entropy of activation ( Δ S+
‡ϴ > 0) . The enthalpic 
barrier for the addition of a monomeric peptide to a fibril, measured here for Aβ42 as 
Δ H+
‡ϴ = 55 ± 5 kJ mol−1, is likely to represent the breakage of hydrogen bonds (and other 
interactions) associated with solvation and with the ensemble of internal structures of the Aβ 
peptide. By contrast, the favorable entropy of the transition state, T Δ S+
‡ϴ = 49 ± 5 kJ mol−1
(at 298K), can be attributed to the desolvation of hydrophobic segments of the incoming 
polypeptide and the fibril end. Remarkably, these values for the energy barriers associated 
with fibril elongation in solution are in agreement with previous two-state measurements of 
the elongation of surface-immobilized Aβ42 fibrils33, 35.
Moreover, the present strategy, which makes it possible to decouple and characterise the 
activation energies of complex processes in solution, also reveals the energy barriers for 
primary nucleation and secondary nucleation. The values determined for the barriers to 
primary nucleation (Fig. 4) follow the same overall trend to the elongation process 
( Δ Hn
‡ϴ > 0 and Δ Sn
‡ϴ > 0), indicating that fibril elongation and primary nucleation share 
fundamental qualitative similarities. The high activation energy for primary nucleation 
( Δ Gn
‡ϴ = 65 ± 2 kJ mol−1) consists of an enthalpic barrier ( Δ Hn
‡ϴ = 144 ± 25 kJ mol−1) and a 
favorable entropy of activation (T Δ Sn
‡ϴ = 79 ± 26 kJ mol−1) . These values have the same 
signs as the barriers for the elongation process, but have larger magnitudes, as would be 
expected for this slow nucleation process. Indeed, the free energy of activation determined 
here for primary nucleation is approximately 10 times larger than for fibril elongation. This 
increase occurs in spite of a more favourable entropy of activation and is driven by the much 
larger enthalpic barrier observed for primary nucleation relative to elongation.
The qualitative similarity in the data obtained for primary nucleation and fibril elongation 
implies that the hydrophobic effect also plays a dominant role in primary nucleation, and 
that the rate-limiting step in this process can be understood as an overall transition similar to 
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fibril elongation, albeit requiring more extensive bond breaking. Specifically, the data show 
that the magnitude of the enthalpic barrier for primary nucleation is more than two times 
greater than the equivalent barrier for elongation, whereas the magnitude of the favourable 
entropic contributions are similar. The increase in the enthalpic barrier can be rationalised by 
noting that in forming a nucleus, the relevant hydrogen bonds associated with solvation must 
be broken in two monomers7, in contrast to the elongation process where the penalty 
corresponds to a single monomer being added to a partially desolvated existing fibril end 15, 
32. Conversely, the rough similarity between the favourable entropies of activation measured 
for fibril elongation and primary nucleation is likely a consequence of the fact that in both 
processes an interface of similar size is desolvated. Interestingly, the data reveal a slightly 
less favourable entropy of activation for the elongation process, which may be explained by 
the fact that the terminal monomer at the fibril end in the elongation process is already 
partially desolvated relative to a free monomer. It is also interesting to note that the different 
magnitudes of the enthalpic barriers measured here for nucleation and elongation are in 
contrast to simple colloidal models of one-dimensional growth, where the energy barriers to 
nucleation and elongation are identical36. The increased enthalpic barrier for primary 
nucleation observed here thus reflects the large number of internal and solvent degrees of 
freedom associated with the peptide.
The results for secondary nucleation are in quantitative and qualitative contrast to those for 
fibril elongation and primary nucleation. The secondary nucleation process involves existing 
fibrils catalysing the nucleation of new aggregates from monomeric peptide. By definition, 
as a catalysed reaction, the energy barrier of secondary nucleation must be reduced relative 
to primary nucleation. This prediction is verified by the measurement of the activation 
energy of secondary nucleation as Δ G2
‡ϴ = 16 ± 2 kJ mol−1, which represents a four-fold 
reduction in the energy barrier relative to primary nucleation, demonstrating the remarkably 
effective manner in which amyloid fibrils catalyse the nucleation of new aggregates from 
monomers. Strikingly, in addition to this dramatic lowering of the activation energy relative 
to primary nucleation, the enthalpic and entropic contributions to the free energy barrier are 
reversed in sign ( Δ H2
‡ϴ < 0 and Δ S2
‡ϴ < 0) . By contrast to the enthalpic barriers and 
favorable changes in entropy observed for primary nucleation and fibril elongation, the 
energy barrier for secondary nucleation is entirely entropic (T Δ S2
‡ϴ = − 27 ± 8 kJ mol−1)
with a small negative enthalpic barrier ( Δ H2
‡ϴ = − 11 ± 7 kJ mol−1) . In what follows we 
analyse in detail the energy landscape of secondary nucleation.
Mapping the energy landscape for secondary nucleation
Elementary chemical reactions are typically associated with positive enthalpies of activation, 
while the data obtained here for secondary nucleation, which is a multimolecular reaction 
governed by diffusion dynamics, reveal a negative value. In order to gain additional 
mechanistic insight into the secondary nucleation process, we therefore mapped the reactive 
trajectory to construct a more complete picture of the energy landscape. To achieve this goal, 
we measured directly the interactions between monomeric peptides and the surfaces of 
fibrils as a function of concentration and temperature using surface plasmon resonance 
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(SPR). The results (Fig. 5a) reveal strikingly that the surface coverage of monomers on the 
fibril surfaces decreases with increasing temperature.
In general, the rate of secondary nucleation can be written as r2(T, c) = kr(T)θ(T, c)n2, where 
θ(T, c) is the fibril surface coverage determined directly via SPR measurements39, c is the 
monomer concentration, n2 is the reaction order7, and kr(T) is the rate constant of the 
surface catalysed reaction. In the limit of low surface coverage, θ(T, c) = α(T)c, where α(T) 
is the inverse of the peptide-fibril equilibrium dissociation constant, α(T) = 1/KD(T) (see the 
Supplementary Note for a detailed derivation). In this case the rate of secondary nucleation 
reduces to r2(T, c) = k2(T)cn2, with k2(T) = kr(T)α(T)n2. The data reveal (Fig. 5b) that the 
surface occupancy of monomers on the fibril surface α(T) decreases with temperature, 
∂α(T)/∂T < 0 (i.e. the adsorption is exothermic), while the rate of the subsequent surface 
catalysed reaction kr(T) increases with temperature, ∂kr/∂T > 0. At higher temperatures, the 
decrease in the concentration of monomers on the fibril surface α(T) is sufficient to 
outweigh the increase in the rate constant controlling the subsequent reaction kr(T), so that 
the overall rate constant of the secondary nucleation process k2(T) decreases as temperature 
increases (Fig. 5b).
Although the major role of the fibril, as the catalytic surface, is to provide a stabilisation of 
the transition state prior to nucleus formation, in this case driven by a favourable enthalpy of 
activation, it is interesting to note that the thermodynamic features uncovered here for 
surface-catalyzed secondary nucleation are reminiscent to those of classical heterogeneous 
catalysis of a reaction at a solid surface40.
This data for the adsorption of monomers onto the fibril surface also directly provides access 
to the change with adsorption in free energy through Δ Gads
ϴ = − RT log(α(T)cϴ) .
Furthermore, the corresponding change in enthalpy is given by the Clausius Clapeyron 
equation Δ Hads
ϴ = − R ∂α/ ∂(1/T) and the change in entropy may be calculated since 
T Δ Sads
ϴ = Δ Hads
ϴ − Δ Gads
ϴ
 (see the Supplementary Note for detailed calculations). By 
combining these direct measurements of the adsorption process with the results from bulk 
solution, we are able to map out the energy landscape for secondary nucleation (Fig. 5c) that 
characterises the transition from the initial reactants, through the adsorbed monomers on the 
fibril and the subsequent nucleation reaction, to the final products. Note that the free energy 
of the final products is known via equilibrium measurements of the critical concentration 
ccrit10, which gives Δ Gflb
ϴ = RT ln(ccrit/c
ϴ) ≈ − 46kJ mol−1 at protein concentration cϴ = 1 
M. Since our experiments are typically at micromolar concentrations, which are significantly 
closer to physiologically relevant conditions than a standard state of 1M, the energy 
landscape for secondary nucleation can also be calculated assuming a standard state of 1μM 
(Supplementary Fig. 6).
It is interesting to note from the energy landscape that the difference in enthalpy between the 
adsorbed state and the highest point on the energy landscape is given by 
Δ H2
‡ − 2 Δ Hads = 123kJ mol
−1, which is similar to the enthalpic barrier determined for 
primary nucleation, Δ Hn
‡ . We can speculate, therefore, that the secondary nucleation 
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reaction that occurs after the adsoroption of monomers onto the fibril surface may share 
similar characteristics with primary nucleation in solution.
Discussion
The results presented here are the first determination of the thermodynamic signatures of the 
key microscopic steps in Aβ amyloid formation. The activation energies determined for 
primary nucleation and fibril elongation reveal that these processes are controlled by 
enthalpic barriers and favourable entropies of activation (ΔH‡ϴ > 0, ΔS‡ϴ > 0). By contrast, 
the results for secondary nucleation reveal remarkably that this process has a fundamentally 
different signature, with the relevant barrier being entropic rather than enthalpic in nature 
(ΔH‡ϴ < 0, ΔS‡ϴ < 0).
Although the primary and secondary nucleation processes both generate new aggregates 
from monomeric peptides, the results here show that these two processes have opposite 
temperature dependencies (Fig. 4b). These observations reveal that the interactions between 
monomeric Aβ and amyloid fibrils are not only able to change the rate constant 
characterising nucleation, but also to fundamentally reverse the thermodynamic signature of 
this process relative to primary nucleation. Moreover, our results show that Aβ42 monomers 
have an intermediate affinity for the surface of amyloid fibrils (KD ≈ 10μM), and indicate a 
mechanism involving the rapid adsorption (and desorption) of monomers prior to a rate-
limiting reaction step on the fibril surface, a process analogous to classical heterogeneous 
catalysis. Indeed, the Sabatier principle states in qualitative terms that for efficient catalysis, 
the affinity between the catalyst and substrate should neither be too strong nor too weak, but 
rather intermediate to allow the substrate to bind and the products to dissociate. This 
classical concept was recently evaluated using DFT calculations leading to predictors of 
catalytic efficiency based on the interactions between surfaces and reactants41. In 
thermodynamic terms, the catalytic efficiency of Aβ42 fibril surfaces can therefore be 
explained through enthalpic stabilisation of conformations amenable to nucleation, resulting 
in a significant lowering of the activation energy barrier. Indeed, the surface-binding of 
monomers is likely to induce a significant structural change in the peptide, consistent with 
the very high specificity that has been observed for the secondary nucleation reaction, as 
demonstrated by the fact that fibrils constructed from other proteins and peptides, including 
Aβ40, are not able to efficiently catalyse nucleation of Aβ42 monomers7, 42.
Through mapping the energy landscapes that characterise the distinct molecular steps in the 
aggregation of Aβ42 into amyloid fibrils, the present study provides foundational insights 
into the molecular mechanism of secondary nucleation, which has been identified as a 
critical step in generating the high levels of toxicity associated with Aβ42 amyloid 
formation. Our results suggest that strategies that seek to interfere with the interactions 
between monomers and fibril surfaces, which drive the unique thermodynamic signature of 
secondary nucleation, may therefore be effective approaches to reducing the toxicity of Aβ 
aggregation. Indeed, we have recently shown that nature has designed molecular chaperones 
capable of binding to Aβ42 fibrils in competition with monomeric peptides, resulting in a 
lower population of surface bound Aβ42 monomers, inhibition of the overall rate of 
secondary nucleation, and the abolition of toxicity in living brain tissue9. Furthermore, the 
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secondary nucleation of new aggregates on fibril surfaces is increasingly recognised as a 
central feature in several amyloid disorders beyond Alzheimer’s disease, ranging from 
Parkinson’s disease to type-II diabetes. It is likely that interactions between monomeric 
peptides and fibril surfaces will become a common target in the development of therapeutics 
which seek to ablate the toxicity associated with amyloid formation. Interestingly, the 
present work indicates that stabilisation of surface-bound monomers on the fibril surface 
could be a complementary approach.
More generally, the approach developed in this study extends the methods commonly used 
to probe the energy landscapes of two-state systems in protein folding to investigations of 
complex protein self-assembly, which involve a multitude of processes occurring 
simultaneously across heterogeneous populations. Probing energy landscapes has for 
decades proved a powerful tool to study reaction mechanisms. With our increasing ability to 
decouple and probe the rates of the individual processes driving self-assembly reactions, we 
expect this approach to have direct applicability across a diverse range of complex 
biochemical phenomena for which mechanistic information is currently challenging to 
achieve, including the more than thirty disease-related amyloid systems and a wide range of 
functional bio-molecular assembly processes involved in cellular structure and molecular 
trafficking.
Methods
Materials
We expressed the Aβ(M1-42) peptide 
(MDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA) in Escherichia coli 
and purified the peptide as described previously44. Aliquots of purified Aβ42 were thawed 
and dissolved in 6 M GuHCl, and the monomer was isolated by two rounds of gel filtration 
on a Superdex 75 column in 20 mM sodium phosphate buffer, pH 8, with 200 μM EDTA and 
0.02% NaN3. The centre of the monomer peak was collected on ice and lyophilized. The 
sample was again dissolved in 6 M GuHCl, and the monomer isolated by gel filtration on a 
Superdex 75 column in 20 mM sodium phosphate buffer, pH 8, with 200 μM EDTA and 
0.02% NaN3 was typically found to have a concentration (determined by quantitative amino 
acid analysis purchased from BMC Uppsala) of 5-12 μM. The gel filtration step removes 
traces of pre-existing aggregates and exchanges the buffer to the one used in the fibril 
formation experiments.
Kinetic assays
The monomer was supplemented with 6 μM ThioflavinT (ThT) and was used to prepare a 
series of samples of Aβ42 with concentrations between 0.5 and 6 μM. All samples were 
prepared in low-bind Eppendorf tubes (Axygen, California, USA) on ice. Samples were 
pipetted into multiple wells of a 96 well half-area plate of black polystyrene with a clear 
bottom and PEG coating (Corning 3881, Massachusetts, USA), 100 μL per well. Assays 
were initiated by placing the 96-well plate at the designated temperature in a plate reader 
(Fluostar Omega, Fluostar Optima or Fluostar Galaxy, BMGLabtech, Offenburg, Germany). 
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A series of control experiments7, 10 demonstrated that under the conditions used, the 
fluorescence from ThT is linearly related to the Aβ42 aggregate mass concentration.
Pre-formed fibrils
Kinetic experiments were set up as above for multiple samples of Aβ42 at 36°C. The 
fluorescence of added ThT was monitored for 1.5 h to verify the formation of fibrils. The 
samples were then collected from the wells into low-bind Eppendorf tubes (Axygen, 
California, USA) and sonicated for 2 min in a sonicator bath at room temperature to disrupt 
any fibril clusters. The previously established rate constants7 for elongation and secondary 
nucleation in Aβ42 aggregation show that at the concentrations of pre-formed fibrils applied 
here, the accelerating effect on the reaction is due primarily to elongation processes induced 
by the added reactive fibril ends.
Surface plasmon resonance studies
The SPR experiments were performed with a Biacore 3000 instrument (GE Healthcare), 
using C3 sensors, essentially as described previously39. The flow rate was 10 μl/min 
throughout using 20 mM phosphate, 0.2 mM EDTA, pH 8.0 with 0.005% Tween20 as the 
flow buffer. The central fraction of Aβ42 peptide monomer from gel filtration in 20 mM 
phosphate, 0.2 mM EDTA, pH 8.0, was collected and stored on ice for up to 8h until use. A 
solution of 10 μM of monomeric peptide was incubated for 2 h at 37°C to form fibrils, 
followed by tip sonication to produce short (ca. 50 nm) fibrils for immobilization. For the 
attachment of the fibrils to the surface of the sensor, the fibrils were diluted 10-fold into 10 
mM sodium acetate buffer at pH 3.0. The carboxylic acid groups on the CM3 sensor surface 
were activated with a mixture of EDC and NHS to enable standard amine coupling 
chemistry. The injection of fibrils led to an increase of ca. 3000 RU. The subsequent 
incubation with monomer in 20 mM phosphate, 0.2 mM EDTA, pH 8.0 added ca. 9000 RU. 
Injection of monomers was followed by buffer flow. The linear parts of the dissociation 
curves were fitted to a linear function which was extrapolated to the beginning of the 
dissociation phase. The difference amplitude relative to baseline was taken to correspond to 
the monomer binding to the fibril surface. The amplitudes, A, were plotted as a function of 
monomer concentration, and fitted to A = A(∞)Kc/(1 + Kc), with K being the binding 
constant and c the monomer concentration.
Kinetic rate laws
Following our previous analysis7, 27, the generation of fibril mass, M, when both primary 
and secondary nucleation events occur is described by the integrated rate law:
M(t)
M(∞) = 1 −
B+ + C+
B+ + C+e
κt
B− + C+e
κt
B− + C+
k∞
2
κk∞e
−k∞t (1)
where two particular combinations of the rate constants for primary nucleation (kn), 
elongation (k+) and fibril-catalysed secondary nucleation (k2) define much of the 
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macroscopic behaviour; these parameters are related to the rate of formation of new 
aggregates through primary pathways λ = 2k+knm(0)
nc
 and through secondary pathways 
κ = 2k+k2m(0)
n2 + 1, where k2 = k− when n2 = 0. Indeed, Eq. 1 depends on the rate constants 
through these two parameters, λ and κ, alone since B± = (k∞ ± k̃∞)/(2κ), C± = ±λ2/(2κ2), 
k∞ = 2κ
2/[n2(n2 + 1)] + 2λ
2/nc and k∞ = k∞
2 − 4C+C−κ
2 . The initial concentration of 
soluble monomers is denoted m(0) and the exponents describing the dependencies of the 
primary and secondary pathways on the monomer concentration are given as nc and n2 
respectively.
Kramers rate theory for multi-well potentials
Kramers rate theory for a double-well potential states that the rate at which the system 
diffuses from one minimum x1 to the other x2 is given by a prefactor A (which depends on 
the curvatures of the potential landscape at x1 and at the barrier x*) multiplied by the 
negative exponential of the highest free energy point measured relative to the starting point. 
When the potential landscape has greater than two local minima, the escape rate is still 
described by an equation of the same form provided that the local minima satisfy certain 
ordering conditions; in particular, for a multi-well potential landscape having local minima 
at x1, x2, … , xn there exists an ordering ≺ of these local minima (obtained by ordering the 
minima from deepest to shallowest) so that the expectation value for the average escape time 
from xk to the set ℳk = {xj|xj ≺ xk} satisfies Kramers formula. The Supplementary Note 
provides a detailed analysis of the temperature dependence of the individual microscopic 
steps involved in secondary nucleation.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Kinetics of Aβ42 aggregation from purely monomeric peptide at different temperatures 
and initial monomer concentrations.
Normalized experimental reaction profiles, monitored by ThT fluorescence, for Aβ42 
aggregation from purely monomeric peptide for different initial concentrations of 
monomeric peptide and at different temperatures (a) 26°C, (b) 29°C, (c) 31°C, (d) 33°C, (e-
f) 36°C, (g) 40°C and (h) 45°C in 20 mM sodium phosphate, 0.2 mM EDTA, 0.02% sodium 
azide, pH 8.0, with 6 µM ThT. The initial concentrations of monomers were 5.0 µM 
(purple), 4.5 µM (red), 4.0 µM (pink), 3.5 µM (orange), 3.0 µM (yellow), 2.5 µM (green), 2.2 
µM (cyan) and 1.9 µM (blue). Note the different scales on the time axes; Supplementary Fig. 
1 shows the data with the same scale for each panel. The data were recorded in two sets of 
four temperatures with measurements at 36°C included in both sets to act as a reference 
condition. The solid lines are global fits at each temperature using the analytical integrated 
rate law for Aβ42 aggregation. Two combinations of the microscopic rate constants, k+kn 
and k+k2, are used to globally fit the entire data set in each panel, in terms of rate constants 
for elongation (k+), primary nucleation (kn) and secondary nucleation (k2). The rate 
parameters determined at each temperature from the global fitting are plotted in Fig. 3a,b.
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Figure 2. Kinetics of pre-seeded Aβ42 aggregation at different temperatures and initial monomer 
concentrations.
Normalized experimental reaction profiles, monitored by ThT fluorescence, for Aβ42 
aggregation in the presence of pre-formed fibrils for different initial concentrations of 
monomeric peptide and at different temperatures (a) 29°C, (b) 33°C, (c) 36°C and (d) 40°C. 
The initial concentrations of monomers were 5.0 µM (yellow), 4.0 µM (pink) and 3.0 µM 
(purple). The solid lines are global fits at each temperature using the analytical integrated 
rate law for Aβ42 aggregation. The data in each panel is fitted globally with a single 
parameter, k+/L(0), where L(0) is the average length of the pre-formed fibrils. The rate 
parameters determined at each temperature from the global fitting are plotted in Fig. 3c.
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Figure 3. Arrhenius behavior of the microscopic rate constants for Aβ42 aggregation.
Arrhenius plots showing the temperature dependence of the rate parameters determined from 
the analytical fitting in Figs. 1, 2: (a) for k+, (b) for the combined rate parameter k+kn, (c) 
for the combined rate parameter k+k2, in terms of rate constants for elongation (k+), primary 
nucleation (kn) and secondary nucleation (k2). (d) shows how the data from (a-c), which is 
plotted as the faded data points and lines, are combined to give the temperature 
dependencies of the individual rate constants. Interestingly, while k+ and kn increase at 
higher temperatures, k2 has a weak temperature dependence with the opposite trend. The 
error bars for the rate parameters represent standard errors from the global fits shown in 
Figs. 1-2 and for the temperatures indicate the ranges of fluctuations recorded during each 
experiment.
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Figure 4. Activation energies of fibril elongation, primary nucleation and secondary nucleation 
in Aβ42 amyloid formation.
(a) The free energies of activation, and the enthalpic and entropic contributions, determined 
from our measurements. The activation energies for elongation and primary nucleation and 
primary nucleation consist of enthalpic barriers and favorable entropies of activation, 
whereas the enthalpic and entropic contributions to the free energy are reversed in sign for 
secondary nucleation. The values and standard errors shown were calculated by fitting the 
data shown in Fig. 3 with ΔH‡ϴ = −R ∂(log k)/∂(1/T) and ΔG‡ϴ = −RT log(k/A), which were 
combined to give TΔS‡ϴ = ΔH‡ϴ −ΔG‡ϴ. The entropic term is shown at T = 298K. The 
values are given per mole of reaction at a standard state of 1M. (b) Schematic showing the 
different temperature dependencies of the two nucleation processes that both generate 
aggregates from monomeric peptides. The structures used in the visual representations of 
each process are adapted from Refs. 45 and 46.
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Figure 5. Mapping the energy landscape for secondary nucleation.
(a) SPR measurements of the adsorption of monomers onto fibrils as a function of 
concentration and temperature. The data are fitted to the Langmuir isotherm to determine 
KD fitted at each temperature. (b) The variation in the surface coverage α(T) = 1/KD(T), the 
rate constant of the subsequent nucleation reaction kr(T), and the overall rate of secondary 
nucleation k2(T) = α(T)2kr(T). The corresponding values of KD are KD(20°C) = 11μM, 
KD(30°C) = 26μM, KD(40°C) = 64μM. (c) The energy landscape for secondary nucleation 
assuming a standard state of 1M, showing the trajectory from starting materials, through 
adsorption and reaction, to products. Since our experiments are typically at micromolar 
concentrations, the same landscape is shown assuming a standard state of 1μM in 
Supplementary Fig. 6, where ΔGads > 0. Note that, according to Kramers theory of diffusive 
reactions, the activation parameters determined from the temperature dependence of the rate 
constants correspond to the highest free energy barrier measured relative to the reactants.
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